1. China FDA accepted as member of Swiss non-profit ICH

   News item 22 July 2017 Pages: 1 - 1

2. EMA: use of MS therapy restricted while under review

   News item 22 July 2017 Pages: 2 - 2

3. Endo voluntarily withdraws Opana ER from US market

   Media release 22 July 2017 Pages: 3 - 3

4. Japan's PMDA revises precautions for multiple products

   News item 22 July 2017 Pages: 4 - 4

5. Methylprednisolone: warnings about lactose-containing products

   News item 22 July 2017 Pages: 5 - 5

6. PRAC: gadolinium deposition confirmed with linear agents

   News item 22 July 2017 Pages: 6 - 6

7. Alendronate may reduce hip fracture risk in prednisolone users

   Clinical study 22 July 2017 Pages: 7 - 7

8. Antimuscarinics: side effect preferences in elderly subjects

   Clinical study 22 July 2017 Pages: 8 - 8

9. Association between proton pump inhibitors and muscular ADRs

   Clinical study 22 July 2017 Pages: 9 - 9

10. Risk of all-cause mortality with benzodiazepines

    Clinical study 22 July 2017 Pages: 10 - 10

11. Serious medical outcomes due to US medication errors

    Clinical study 22 July 2017 Pages: 11 - 11

12. Spontaneously reported medication errors in the EU

    Clinical study 22 July 2017 Pages: 12 - 12

13. 90y-dotatate/octreotate-lu-177-dota-tyr-3

    Case report 22 July 2017 Pages: 13 - 13

14. Abatacept

    Case report 22 July 2017 Pages: 14 - 14

15. Abatacept

    Case report 22 July 2017 Pages: 15 - 15

16. Abatacept

    Case report 22 July 2017 Pages: 16 - 16

17. Acenocoumarol

    Case report 22 July 2017 Pages: 17 - 17

18. Acetylleucine

    Case report 22 July 2017 Pages: 18 - 18

19. Adalimumab

    Case report 22 July 2017 Pages: 19 - 19

20. Adalimumab

    Case report 22 July 2017 Pages: 20 - 20

21. Alirocumab

    Case report 22 July 2017 Pages: 21 - 21

22. Alteplase

    Case report 22 July 2017 Pages: 22 - 22

23. Amikacin/linezolid

    Case report 22 July 2017 Pages: 23 - 23

24. Amiodarone

    Case report 22 July 2017 Pages: 24 - 24

25. Amiodarone

    Case report 22 July 2017 Pages: 25 - 25

26. Amiodarone

    Case report 22 July 2017 Pages: 26 - 26

27. Amiodarone withdrawal

    Case report 22 July 2017 Pages: 27 - 27

28. Amisulpride

    Case report 22 July 2017 Pages: 28 - 28

29. Amlodipine/ramipril

    Case report 22 July 2017 Pages: 29 - 29

30. Amoxicillin

    Case report 22 July 2017 Pages: 30 - 30

31. Amoxicillin/clavulanic acid

    Case report 22 July 2017 Pages: 31 - 31

32. Amphotericin B liposomal

    Case report 22 July 2017 Pages: 32 - 32

33. Antiepileptic drugs

    Case report 22 July 2017 Pages: 33 - 33

34. Antiepileptic drugs

    Case report 22 July 2017 Pages: 34 - 34

35. Antihyperlipidaemics

    Case report 22 July 2017 Pages: 35 - 35

36. Antineoplastics

    Case report 22 July 2017 Pages: 36 - 36

37. Antineoplastics

    Case report 22 July 2017 Pages: 37 - 37

38. Antineoplastics

    Case report 22 July 2017 Pages: 38 - 38

39. Antineoplastics

    Case report 22 July 2017 Pages: 39 - 39

40. Antineoplastics

    Case report 22 July 2017 Pages: 40 - 40

41. Antineoplastics

    Case report 22 July 2017 Pages: 41 - 41

42. Antineoplastics

    Case report 22 July 2017 Pages: 42 - 42

43. Antipsychotics withdrawal

    Case report 22 July 2017 Pages: 43 - 43

44. Antituberculars

    Case report 22 July 2017 Pages: 44 - 44

45. Antivirals

    Case report 22 July 2017 Pages: 45 - 45

46. Apixaban

    Case report 22 July 2017 Pages: 46 - 46

47. Apomorphine

    Case report 22 July 2017 Pages: 47 - 47

48. Apremilast

    Case report 22 July 2017 Pages: 48 - 48

49. Apremilast/ciclosporin

    Case report 22 July 2017 Pages: 49 - 49

50. Aripiprazole/olanzapine

    Case report 22 July 2017 Pages: 50 - 50